The clinical trials performed by Biomics offer its participants the chance to become a part of their own healthcare and to have access to potential novel treatments and drugs before they are commercially available. Such studies offer a significant amount of information towards the advancement of medical care and are vital in terms of uncovering effective cures for type 1 and type 2 diabetes.
When a potentially efficient treatment or drug is developed in our labs and its safety is comprehensively tested in preclinical trials, researchers at Biomics begin conducting clinical trials in patients offering them first-rate care and associated study medicines throughout the duration of the trial with no expenses required on their part.
Type 1 diabetes candidate: Afremlin
Alongside a proper diet and a regular exercise program Afremlin is used to regulate blood sugar levels in individuals diagnosed with type 1 diabetes. Regulating increased sugar levels in the bloodstream helps with averting health risks associated with type 1 diabetes such as blindness, kidney failure, strokes and sexual dysfunctions.
Afremlin is a man manufactured product that is identical to the insulin produced by the human body, thus replacing the insulin that would be normally generated by the pancreas. Afremlin begins functioning faster and lasts longer than regular insulin, assisting glucose to access cells that use it for energy.
Type 2 diabetes candidate: Glucolitol RX
Glucolitol RX is used to regulate blood sugar levels in individuals diagnosed with type 2 diabetes.
It functions by helping the body reestablish its appropriate response to the insulin it normally produces, reducing the amount of sugar produced by the liver and absorbed by the stomach as well as the intestines.
Alongside a balanced diet and regular physical exercises, Glucolitol RX is also expected to prevent the onset of diabetes in individuals at risk of developing the diseases. Likewise it can also be used in women with polycystic ovaries, regulating menstrual cycles and increasing fecundity.
B.I.O – Biomics Insulin Organoid